
<DOC>
<DOCNO>WT01-B04-18</DOCNO>
<DOCOLDNO>IA046-000815-B036-95</DOCOLDNO>
<DOCHDR>
http://www.gothic.net:80/invest/9610021.htm 205.178.27.23 19970119004053 text/html 13261
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sun, 19 Jan 1997 00:43:57 GMT
Content-Type: text/html
Accept-Ranges: bytes
Last-Modified: Sat, 16 Nov 1996 00:25:43 GMT
Content-Length: 13062
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>October 2, 1996</title>
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body bgcolor="#FFFFFF" link="#872659" vlink="#872659"
alink="#FFFFFF">
<table border="0" cellpadding="0" cellspacing="0" width="100%">
    <tr>
        <td>
        <p align="left"><MAP NAME="FrontPageMap"><AREA SHAPE="RECT" COORDS="396, 1, 440, 12" HREF="../people/5_0.htm"><AREA SHAPE="POLYGON" COORDS="344, 11, 374, 2, 391, 16, 394, 30, 371, 37, 368, 61, 349, 59, 341, 33, 344, 11" HREF="../people/5_0.htm"><AREA SHAPE="RECT" COORDS="435, 51, 495, 65" HREF="../product/2_0.htm"><AREA SHAPE="POLYGON" COORDS="406, 27, 424, 46, 428, 72, 407, 94, 386, 90, 385, 84, 369, 66, 369, 61, 371, 38, 406, 27" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="393, 110, 525, 124" HREF="../patent/4_0.htm"><AREA SHAPE="POLYGON" COORDS="330, 75, 366, 64, 384, 86, 390, 110, 366, 134, 334, 126, 325, 103, 330, 75" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="205, 75, 271, 96" HREF="6_0.htm"><AREA SHAPE="POLYGON" COORDS="313, 56, 329, 74, 324, 102, 327, 110, 313, 123, 286, 117, 273, 91, 279, 65, 313, 56" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="196, 26, 282, 41" HREF="../perform/3_0.htm"><AREA SHAPE="POLYGON" COORDS="291, 28, 323, 16, 338, 34, 345, 58, 330, 72, 313, 54, 290, 61, 286, 49, 291, 28" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="8, 2, 105, 25" HREF="../index.htm"><AREA SHAPE="RECT" COORDS="9, 46, 81, 61" HREF="../contact.htm"><AREA SHAPE="RECT" COORDS="10, 62, 80, 77" HREF="../search.htm"><AREA SHAPE="RECT" COORDS="10, 78, 79, 93" HREF="../map.htm"><AREA SHAPE="RECT" COORDS="435, 54, 495, 65" HREF="../product/2_0.htm"><AREA SHAPE="POLYGON" COORDS="406, 27, 424, 46, 428, 72, 407, 94, 386, 90, 385, 84, 369, 66, 369, 61, 371, 38, 406, 27" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="393, 114, 525, 124" HREF="../patent/4_0.htm"><AREA SHAPE="POLYGON" COORDS="330, 75, 366, 64, 384, 86, 390, 110, 366, 134, 334, 126, 325, 103, 330, 75" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="205, 75, 271, 96" HREF="6_0.htm"><AREA SHAPE="POLYGON" COORDS="313, 56, 329, 74, 324, 102, 327, 110, 313, 123, 286, 117, 273, 91, 279, 65, 313, 56" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="196, 30, 282, 41" HREF="../perform/3_0.htm"><AREA SHAPE="POLYGON" COORDS="291, 28, 323, 16, 338, 34, 345, 58, 330, 72, 313, 54, 290, 61, 286, 49, 291, 28" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="8, 2, 105, 25" HREF="../index.htm"><AREA SHAPE="RECT" COORDS="9, 46, 81, 61" HREF="../contact.htm"><AREA SHAPE="RECT" COORDS="10, 62, 80, 77" HREF="../search.htm"><AREA SHAPE="RECT" COORDS="10, 78, 79, 93" HREF="../map.htm"><AREA SHAPE="RECT" COORDS="435, 54, 495, 65" HREF="../product/2_0.htm"><AREA SHAPE="POLYGON" COORDS="406, 27, 424, 46, 428, 72, 407, 94, 386, 90, 385, 84, 369, 66, 369, 61, 371, 38, 406, 27" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="393, 114, 525, 124" HREF="../patent/4_0.htm"><AREA SHAPE="POLYGON" COORDS="330, 75, 366, 64, 384, 86, 390, 110, 366, 134, 334, 126, 325, 103, 330, 75" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="205, 75, 271, 96" HREF="6_0.htm"><AREA SHAPE="POLYGON" COORDS="313, 56, 329, 74, 324, 102, 327, 110, 313, 123, 286, 117, 273, 91, 279, 65, 313, 56" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="196, 30, 282, 41" HREF="../perform/3_0.htm"><AREA SHAPE="POLYGON" COORDS="291, 28, 323, 16, 338, 34, 345, 58, 330, 72, 313, 54, 290, 61, 286, 49, 291, 28" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="8, 2, 105, 25" HREF="../index.htm"><AREA SHAPE="RECT" COORDS="9, 46, 81, 61" HREF="../contact.htm"><AREA SHAPE="RECT" COORDS="10, 62, 80, 77" HREF="../search.htm"><AREA SHAPE="RECT" COORDS="10, 78, 79, 93" HREF="../map.htm"><AREA SHAPE="RECT" COORDS="435, 54, 495, 65" HREF="../product/2_0.htm"><AREA SHAPE="POLYGON" COORDS="406, 27, 424, 46, 428, 72, 407, 94, 386, 90, 385, 84, 369, 66, 369, 61, 371, 38, 406, 27" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="393, 114, 525, 124" HREF="../patent/4_0.htm"><AREA SHAPE="POLYGON" COORDS="330, 75, 366, 64, 384, 86, 390, 110, 366, 134, 334, 126, 325, 103, 330, 75" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="205, 75, 271, 96" HREF="6_0.htm"><AREA SHAPE="POLYGON" COORDS="313, 56, 329, 74, 324, 102, 327, 110, 313, 123, 286, 117, 273, 91, 279, 65, 313, 56" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="196, 30, 282, 41" HREF="../perform/3_0.htm"><AREA SHAPE="POLYGON" COORDS="291, 28, 323, 16, 338, 34, 345, 58, 330, 72, 313, 54, 290, 61, 286, 49, 291, 28" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="8, 2, 105, 25" HREF="../index.htm"><AREA SHAPE="RECT" COORDS="9, 46, 81, 61" HREF="../contact.htm"><AREA SHAPE="RECT" COORDS="10, 62, 80, 77" HREF="../search.htm"><AREA SHAPE="RECT" COORDS="10, 78, 79, 93" HREF="../map.htm"><AREA SHAPE="RECT" COORDS="435, 54, 495, 65" HREF="Rhttp://206.24.121.44/product/2_0.htm"><AREA SHAPE="POLYGON" COORDS="406, 27, 424, 46, 428, 72, 407, 94, 386, 90, 385, 84, 369, 66, 369, 61, 371, 38, 406, 27" HREF="Rhttp://206.24.121.44/product/2_0.htm"><AREA SHAPE="RECT" COORDS="393, 114, 525, 124" HREF="Rhttp://206.24.121.44/patent/4_0.htm"><AREA SHAPE="POLYGON" COORDS="330, 75, 366, 64, 384, 86, 390, 110, 366, 134, 334, 126, 325, 103, 330, 75" HREF="Rhttp://206.24.121.44/patent/4_0.htm"><AREA SHAPE="RECT" COORDS="205, 75, 271, 96" HREF="Rhttp://206.24.121.44/invest/6_0.htm"><AREA SHAPE="POLYGON" COORDS="313, 56, 329, 74, 324, 102, 327, 110, 313, 123, 286, 117, 273, 91, 279, 65, 313, 56" HREF="Rhttp://206.24.121.44/invest/6_0.htm"><AREA SHAPE="RECT" COORDS="196, 30, 282, 41" HREF="Rhttp://206.24.121.44/perform/3_0.htm"><AREA SHAPE="POLYGON" COORDS="291, 28, 323, 16, 338, 34, 345, 58, 330, 72, 313, 54, 290, 61, 286, 49, 291, 28" HREF="Rhttp://206.24.121.44/perform/3_0.htm"><AREA SHAPE="RECT" COORDS="8, 2, 105, 25" HREF="Rhttp://206.24.121.44/index.htm"><AREA SHAPE="RECT" COORDS="9, 46, 81, 61" HREF="Rhttp://206.24.121.44/contact.htm"><AREA SHAPE="RECT" COORDS="10, 62, 80, 77" HREF="Rhttp://206.24.121.44/search.htm"><AREA SHAPE="RECT" COORDS="10, 78, 79, 93" HREF="Rhttp://206.24.121.44/map.htm"></MAP><a
        href="../_vti_bin/shtml.exe/invest/9610021.htm/map"><img
        align="left" src="../images/newnav.gif" width="528" ismap
        usemap="#FrontPageMap" hspace="0" height="136" border="0"></a></p>
        </td>
    </tr>
    <tr>
        <td>
        <p align="left"><MAP NAME="FrontPageMap1"><AREA SHAPE="RECT" COORDS="30, 67, 252, 80" HREF="6_4.htm"><AREA SHAPE="RECT" COORDS="118, 40, 306, 60" HREF="6_0.htm"></MAP><a
        href="../_vti_bin/shtml.exe/invest/9610021.htm/map1"><img
        src="images/6_4_top.gif" width="307" ismap
        usemap="#FrontPageMap1" height="81" border="0"></a><br>
        <font color="#800040" size="2"><sup><strong><img
        src="images/6_4_bottom.gif" width="60" height="22"></strong></sup></font><font
        color="#800040" size="4"><sup><strong>OCTOBER 2, 1996</strong></sup></font></p>
        </td>
    </tr>
</table>
<table border="0" width="530">
    <tr>
        <td>
        <p align="center"><font size="4"><b>SUPERGEN RECEIVES
        PATENT ALLOWANCE FOR EXTRA</b><sup><b>TM</b></sup><b>
        TECHNOLOGY</b></font></p>
        <p align="center"><font size="4"><b>-- Technology Used In
        Formulation Of &quot;Supergeneric&quot; Anticancer Drugs
        --</b></font></p>
        <blockquote>
            <p>EMERYVILLE, CA (October 2, 1996) -- SuperGen, Inc.
            (Nasdaq: SUPG &amp; SUPGW), a development stage
            pharmaceutical company, today announced it has
            received a U.S. patent allowance for its proprietary
            Extra<sup>TM</sup> technology for use in the
            reformulation of anticancer drugs. SuperGen currently
            is applying this technology to five existing
            anticancer drugs: mitomycin, doxorubicin,
            daunorubicin, paclitaxel and cisplatin. The company's
            first drug in this area, MitoExtra<sup>TM</sup>,
            currently is in Phase II human clinical trials.</p>
            <p>SuperGen believes its Extra<sup>TM</sup>
            technology may significantly enhance the safety
            profile and handling characteristics of certain
            existing anticancer drugs by providing stable,
            ready-to-inject solutions that diminish the handling
            risks for health care providers that are associated
            with mixing current powder formulations prior to
            injection, and by diminishing the ulceration risks to
            patients by &quot;shielding&quot; the drug at the
            injection site.</p>
            <p>&quot;Supergenerics are the second tier of our
            three-tiered product strategy and this patent
            allowance solidifies our dominant ownership of the
            product area,&quot; said Joseph Rubinfeld, Ph.D.,
            SuperGen's Chairman and Chief Executive Officer.
            &quot;With our strong proprietary position we intend
            to expand the use of this technology beyond our
            initial five product targets.&quot;</p>
            <p>Based in Emeryville, CA, SuperGen is a development
            stage pharmaceutical company dedicated to the
            development and commercialization of products
            intended to treat life-threatening diseases,
            particularly cancer and blood cell disorders, as well
            as other serious conditions such as obesity. SuperGen
            is developing its anticancer portfolio of ten generic
            products and five enhanced or
            &quot;supergeneric&quot; products. Blood cell
            disorder products under development currently target
            anemias associated with chemotherapy and
            radiotherapy, renal failure and aplastic anemia. The
            company's obesity pill currently is in Phase II human
            clinical trials.</p>
            <p><font size="2"><i>This press release contains
            forward looking statements that involve certain risks
            and uncertainties associated with a development stage
            pharmaceutical company. Actual results could differ
            materially from those projected in the forward
            looking statements as a result of the risk factors
            discussed in SuperGen</i></font><font size="2"
            face="WP TypographicSymbols"><i>'</i></font><font
            size="2"><i>s reports on file with the U.S.
            Securities Exchange Commission (including but not
            limited to the report on Form 10-Q for the quarter
            ended June 30, 1996).</i></font></p>
        </blockquote>
        <p>&#160; </p>
        </td>
    </tr>
    <tr>
        <td><a href="6_4.htm"><font color="#731754" size="5"><b><img
        src="../images/invesbut.gif" align="middle" border="0"
        width="21" height="20"></b></font><font color="#731754"
        size="4"><b>Return to Press Release Archive</b></font></a></td>
    </tr>
</table>
<p><MAP NAME="FrontPageMap2"><AREA SHAPE="RECT" COORDS="67, 8, 115, 19" HREF="../people/5_0.htm"><AREA SHAPE="RECT" COORDS="128, 9, 191, 19" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="199, 9, 342, 19" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="347, 9, 407, 19" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="415, 10, 506, 20" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="128, 11, 186, 19" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="204, 11, 336, 19" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="353, 11, 403, 19" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="420, 11, 504, 19" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="128, 11, 186, 19" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="204, 11, 336, 19" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="353, 11, 403, 19" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="420, 11, 504, 19" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="128, 11, 186, 19" HREF="../product/2_0.htm"><AREA SHAPE="RECT" COORDS="204, 11, 336, 19" HREF="../patent/4_0.htm"><AREA SHAPE="RECT" COORDS="353, 11, 403, 19" HREF="6_0.htm"><AREA SHAPE="RECT" COORDS="420, 11, 504, 19" HREF="../perform/3_0.htm"><AREA SHAPE="RECT" COORDS="128, 11, 186, 19" HREF="Rhttp://206.24.121.44/product/2_0.htm"><AREA SHAPE="RECT" COORDS="204, 11, 336, 19" HREF="Rhttp://206.24.121.44/patent/4_0.htm"><AREA SHAPE="RECT" COORDS="353, 11, 403, 19" HREF="Rhttp://206.24.121.44/invest/6_0.htm"><AREA SHAPE="RECT" COORDS="420, 11, 504, 19" HREF="Rhttp://206.24.121.44/perform/3_0.htm"></MAP><a href="../_vti_bin/shtml.exe/invest/9610021.htm/map2"><img
src="../images/lowNAV.gif" width="530" ismap
usemap="#FrontPageMap2" height="31" border="0"></a> </p>
</body>
</html>
</DOC>